Table 3.
The ratios of Treg (CD4+CD25+FOXP3) cells to Th17 or Th1 in type 2 diabetes patients.
| Ratios | All type 2 diabetes (AD) (n = 40) |
Diabetes with CHD (n = 16) |
Diabetes without CHD (n = 24) |
Healthy control subjects (n = 30) |
|---|---|---|---|---|
| Treg/Th1 cells | 0.351 ± 0.1* | 0.313 ± 0.1* | 0.131 ± 0.05∗∗Ψ | 0.638 ± 0.08 |
| Treg/Th17 cells | 0.302 ± 0.04** | 0.354 ± 0.05** | 0.26 ± 0.03∗∗∗Ψ | 0.654 ± 0.09 |
*P < 0.05, **P < 0.01, and ***P < 0.001 versus healthy control subjects.
ΨP < 0.05 versus diabetes without CHD.